BASECAMP-1: Leveraging human leukocyte antigen (HLA) loss of heterozygosity (LOH) in solid tumors by next-generation sequencing (NGS) to identify patients with relapsed solid tumor for future logic-gated Tmod CAR T-cell therapy Simeone, D. M., Hecht, J., Patel, S., Morelli, M., Kirtane, K., Borad, M. J., Maus, M., Sunwoo, J. B., Welling, T., Lin, Y., Garon, E. B., Kopetz, S., Locke, F. L., Liechty, K. B., Lozac'hmeur, A., Beutner, K., Ng, E., Go, W. Y., Maloney, D. G., Molina, J. R. LIPPINCOTT WILLIAMS & WILKINS. 2022

View details for Web of Science ID 000863680304843